The physician-researcher faced questions on funding, staffing, and research in his confirmation to lead the world’s largest health research organization.
Dr. Jay Bhattacharya, nominee for director of the National Institutes of Health (NIH), proposed to transform the agency’s research and restore public trust in the institution at his confirmation hearing on March 5.
The physician and former Stanford University professor first drew public attention in 2020 for his criticism of COVID-19-era interventions such as mask mandates, lockdowns, and school closures.
Bhattacharya and others argued for “focused protection” of vulnerable people while allowing low-risk groups to resume normal activities.
He later sued the government, alleging that it pressured social media companies to censor his views.
President Donald Trump nominated Bhattacharya in November 2024 to lead NIH with its $50 billion budget and staff of more than 25,000.
Bhattacharya faced two hours of questions from the Senate Committee on Health, Education, Labor, and Pensions.
Here are the major concerns voiced by lawmakers and how the nominee responded to them.
Restoring Trust
Subcommittee Chairman Bill Cassidy (R-La.) opened the session by pointing to what he called a widespread loss of trust in public health and scientific institutions.
“To restore that trust, officials need to be more transparent and provide reassurance that they are publishing health guidance that is best for Americans’ health and not biased in any way,” Cassidy said.
“What I have seen is that there’s tremendous distrust in medicine and science coming out of the pandemic.”
Bhattacharya said a key to restoring trust is to make NIH research more rigorous.
“NIH-supported science should be replicable, reproducible, and generalizable,” he said, recalling a recent research integrity scandal within the agency that called into question the validity of some studies on Alzheimer’s disease.
“NIH can and must solve the crisis of scientific data reliability.”
Wider Access to Funding, Broader Research Focus
NIH research grants are too narrowly concentrated on favored viewpoints and subject areas, according to Cassidy.
“The current system incentivizes established scientists who study already proven concepts rather than younger scientists who have unproven ideas with potential as major medical breakthroughs,” he said.
